Further supporting a tumor-suppressor role for this miR, Guan et al. [35] demonstrated a role for miR-495 in regulation of the RTK human epidermal growth factor receptor 2 (HER2), which plays a key role in BC progression. The gene discussed is ERBB2; the disease is breast cancer.